Scientist 1/Senior Engineer 1 – Pilot Lab Lead
Sail Biomedicines
Scientist 1/Senior Engineer 1 – Pilot Lab Lead
Sail Biomedicines
In vivo programmable RNA CAR-T therapies
The Scientist I/Senior Engineer I, Pilot Lab lead will oversee a pilot laboratory responsible for producing engineered RNA (eRNA) and targeted lipid nanoparticles (tLNPs). A primary responsibility is the regular execution and delivery of gram-scale eRNA and/or tLNP manufacturing campaigns. This individual will manage direct reports while remaining actively involved in laboratory operations. They will create an organized, efficient, and scalable working environment; introduce and improve processes; and ensure that manufacturing activities are completed safely, consistently, on schedule, and with accurate documentation. The role requires independent judgment, strong scientific or engineering acumen, and effective cross-functional collaboration.
Key Responsibilities:
Requirements for Either Level:
Qualifications:
Scientist I
Senior Engineer I
Preferred Qualifications:
Salary Range: $100,000 - $150,000
Sail Biomedicines is an Equal Opportunity Employer. Sail does not discriminate based on race, religion, color, sex, gender identity, sexual orientation, age, national origin, veteran status, or any other status protected under federal, state, or local law.
In vivo programmable RNA CAR-T therapies
Sail Biomedicines creates programmable RNA medicines that enable in vivo CAR-T therapies for autoimmune diseases, turning the patient’s body into the site of T-cell engineering. Its platform combines Endless RNA circular RNA, a library of targeted nanoparticles for cell-specific delivery, and AI-powered design tools to program T cells inside the body. It differentiates from competitors by delivering and programming CAR-T cells in vivo rather than via ex vivo cell manufacturing, leveraging circular RNA and targeted nanoparticles, with support from its Flagship Pioneering lineage and a Johnson & Johnson collaboration. The goal is to provide scalable, durable immune resets and remission for immune-mediated diseases with broader, more accessible treatments.
Explore more opportunities at Sail Biomedicines